Siena Biotech Buys More Licenses to GeneGo's MetaCore | GenomeWeb
NEW YORK (GenomeWeb News) - GeneGo said today that Siena Biotech has expanded its collection of MetaCore licenses by an undisclosed amount.
 
Siena is using the MetaCore technology to integrate multiple data types including proteomics and chemogenomics information.
 
Financial terms were not disclosed.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.